Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,553,025
+$285,604 QoQ
Shares Held
6,115
+17.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#2,576
of 4,676 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cromwell Holdings LLC holds $10,835,906 across 15 Drug Manufacturers - General names. JNJ ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,613 | $3,134,110 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
6,115 | $1,553,025 | |
| 3 | ABBV |
AbbVie Inc.
|
5,893 | $1,482,913 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,577 | $973,644 | |
| 5 | NVS |
Novartis AG
|
4,117 | $645,216 | |
| 6 | AMGN |
Amgen Inc
|
1,713 | $620,311 | |
| 7 | AZN |
Astrazeneca PLC
|
3,059 | $580,047 | |
| 8 | PFE |
Pfizer Inc
|
18,615 | $448,248 |
All Filings in JNJ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,553,025 | 6,115 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,267,421 | 5,185 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $999,568 | 4,830 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $893,538 | 4,819 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $717,314 | 4,696 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $863,197 | 5,205 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $676,966 | 4,681 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $832,016 | 5,134 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $743,662 | 5,088 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||